No Prescription |
 |
 | ||
|
BENCID Benemid |
|
| ||
No Prescription » Prescription Drugs 2 » BENCID Benemid This medication is used to prevent gout and gouty arthritis. It will not treat a sudden/severe attack of gout and may make it worse. Probenecid belongs to a class of drugs known as uricosurics. It lowers high levels of uric acid in your body by helping the kidneys to get rid of uric acid. When uric acid levels get too high crystals can form in the joints causing gout. Lowering uric acid levels may also help your kidneys.Probenecid is sometimes used along with penicillin antibiotics (e.g. penicillin ampicillin nafcillin) to increase antibiotic blood levels. This increase makes the antibiotic work better at treating certain infections. Probenecid works by decreasing the kidneys' ability to remove the antibiotic from the body.Probenecid should not be used in children younger than 2 years.How to use Probenecid OralTo prevent gout take this medication by mouth usually twice daily with food or antacids to reduce stomach upset or as directed by your doctor. It is best to drink a full glass of water with each dose and at least another 8 glasses (8 ounces each) a day while taking this drug in order to prevent kidney stones. If you are on restricted fluid intake consult your doctor for further instructions. Your doctor may also instruct you on how to decrease acidity in your urine (e.g. avoid large amounts of ascorbic acid/vitamin C) to prevent kidney stones. Your doctor may order other medications (e.g. sodium bicarbonate citrate) to make your urine less acidic.Dosage is based on your condition and response to therapy. Your doctor may Online you to take a low dose at first then adjust your dose based on uric acid levels and your gout symptoms. After you have been symptom-free for several months and your uric acid levels are normal your doctor may lower your probenecid dose to the lowest effective dose. Follow your doctor's directions carefully.Probenecid should not be started during a sudden/severe gout attack. Wait until your current attack is over before starting this medication. You may experience an increase in the number of gout attacks for several months after starting this medicine while the body removes extra uric acid. If you have a gout attack while taking probenecid continue taking it along with your medications for gout pain.Probenecid is not a pain reliever. To relieve pain from gout continue to take your medicines prescribed for pain from gout attacks (e.g. colchicine ibuprofen indomethacin) as directed by your doctor.If you are taking this medication to raise the level of antibiotics in your body follow your doctor's directions for when to take the antibiotic and when to take the probenecid.Use this medication regularly to get the most benefit from it. To help you remember take it at the same times each day.Inform your doctor if your condition persists or worsens. Buy BENCID Benemid and other Prescription Drugs 2 products online at Medstore. 407
About BENCID Benemid: Product Type: Prescription Drugs 2 BENCID ( Benemid Probalan Generic Probenecid ) BENCID (Benemid Probalan Generic Probenecid) Benemid Probalan Generic Probenecid 500mg tabs 30 (3 x 10) Benemid Probalan Generic Probenecid BENCID
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
